Genpact LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
AQR Capital Management reports a beneficial ownership stake of 5.07% in Genpact LTD as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 6.14% in Genpact Ltd, holding over 10.4 million shares.
NYSE
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10,405,025.34 shares, representing 6.1% of Genpact Ltd's common stock, as of June 30, 2026.
NYSE
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 11,278,646 shares of Genpact LTD common stock, representing 6.64% of the class.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Genpact Ltd.
NYSE
Vanguard Portfolio Management has disclosed beneficial ownership of 5.12% of Genpact Ltd's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Genpact Ltd following an internal realignment.
NYSE
Fiduciary Management, Inc. has reported a 5.0% beneficial ownership stake in Genpact LTD's common stock as of February 14, 2025, according to a Schedule 13G filing.
NYSE
Fiduciary Management, Inc. has disclosed a significant beneficial ownership stake of 5.2% in Genpact LTD, primarily for investment purposes.
NYSE
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have jointly disclosed a beneficial ownership of 11.4% in Genpact Ltd's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a continued 9.0% beneficial ownership stake in Genpact Ltd. as of December 31, 2024.
NYSE
Victory Capital Management, Inc. has filed a Schedule 13G, disclosing a 5.59% beneficial ownership stake in Genpact LTD's common stock.